1 Experiments were designed to investigate the mechanisms underlying the diabetes-related impairment of the vasodilatations of the perfused mesenteric arterial bed induced by acetylcholine (ACh) and K + .
Introduction
The endothelium plays an important role in the control of vascular tone via the release of a number of vasodilator substances. These include endothelium-derived relaxing factor (EDRF) (Furchgott & Zawadzki, 1980) , now identi®ed as nitric oxide (NO) (Palmer et al., 1987) , prostaglandin I 2 (PGI 2 ) (Moncada et al., 1976) and endothelium-derived hyperpolarizing factor (EDHF) (Chen et al., 1988; Komori & Vanhoutte, 1990; Garland et al., 1995) . Hyperpolarization may make an important contribution to vasodilatation, particularly in small resistance arteries, where a change in membrane potential of a few millivolts may cause a substantial change in vessel diameter (Nelson et al., 1990; Brayden & Nelson, 1992) , and it has been reported that tissue perfusion is predominantly regulated by resistance arteries (i.e. small arteries with diameters of 5500 mm) (Mulvany & Aalkjaer, 1990) .
There are a number of candidates for EDHF. These include epoxyeicosatrienoic acids (EETs), which are cytochrome P-450 monooxygenase-arachidonic acid metabolites, and the endocannabinoid anandamide, which is also derived from arachidonic acid (Hecker et al., 1994; Campbell et al., 1996; Mombouli & Vanhoutte, 1997; Randall & Kendall, 1998; Fisslthaler et al., 1999) . Recently, some interesting evidence has suggested that K + is also a candidate for EDHF, its action being exerted via its eux through charybdotoxin-and apamin-selective K + channels on endothelial cells (Edwards et al., 1998) . Whatever the exact chemical identity of EDHF, this factor elicits relaxation by activating K + channels, leading to hyperpolarization in smooth muscle cells (Taylor & Weston, 1988) . Furthermore, it has been reported that the contribution of EDHF to endothelium-dependent relaxations increases as the vessel size decreases (Tomioka et al., 1999) .
Diabetes mellitus is associated with vascular complications, including an impairment of vascular function and alterations in the reactivity of blood vessels to neurotransmitters in the macro-and microvasculature. There is an accumulating body of evidence to show that the relaxation responses induced in aortic strips by endothelium-dependent agents are weaker in streptozotocin (STZ)-induced diabetic rats than in normal controls (Oyama et al., 1986; Pieper & Gross, 1988; Kamata et al., 1989a,b; Poston & Taylor, 1995) . A recent report suggested that an impairment of the endothelium-dependent hyperpolarization induced by ACh may be present in mesenteric arteries from STZ-induced diabetic rats (Fukao et al., 1997) .
In the present study, the experiments were designed to investigate the mechanisms underlying the diabetes-related impairment of the acetylcholine (ACh)-induced endotheliumdependent vasodilatation of the perfused mesenteric arterial bed. We were especially interested in determining whether K is able to cause vasodilatation in the mesenteric arterial bed and, if so, how the K + -induced vasodilatation might be altered in the diabetic state.
Methods

Animals and induction of diabetes mellitus
Male Wistar rats, 8 weeks old and 220 ± 250 g in weight, received a single injection via the tail vein of STZ 66 mg kg 71 , dissolved in citrate buer. Age-matched control rats were injected with the buer alone. Food and water were available ad libitum to all animals. Blood pressure and heart rate were recorded by the tail-cu method. This study was conducted in accordance with the Guide for the Care and Use of Laboratory Animals adopted by the Committee on the Care and Use of Laboratory Animals of Hoshi University (which is accredited by the Ministry of Education, Science, Sports and Culture, Japan).
Measurement of plasma insulin, glucose, cholesterol and triglyceride
Plasma insulin was measured by radioimmunoassay (Amersham International plc., Buckinghamshire, U.K.). The concentration of glucose in the plasma was determined by the Otoluidine method. Plasma cholesterol levels and triglyceride levels were determined by the use of a commercially available enzyme kit (Wako Pure Chemical Co. Ltd., Osaka, Japan).
Preparation of the perfused mesenteric arterial bed
Ten weeks after treatment with STZ or buer, rats were anaesthetized with ether and then given an intravenous injection of 1000 units kg 71 of heparin. Following this injection, the mesenteric arterial bed was rapidly dissected out and placed into modi®ed Krebs-Henseleit solution (KHS, composition in mM: NaCl 118; KCl 4.7; NaHCO 3 25; CaCl 2 1.8; NaH 2 PO 4 1.2; MgSO 4 1.2; dextrose 11; 0.25% bovine serum albumin). The mesenteric artery and vein were tied o near the caecum, and the remaining intestine was then separated from the arterial bed along the intestinal wall. The mesenteric arterial bed was then perfused using the method described previously by us (Kamata & Makino, 1997; . Brie¯y, warm (378C), oxygenated (95% O 2 ± 5% CO 2 ) KHS was pumped into the mesenteric arterial bed, using a peristaltic pump operating at a rate of 5 ml min 71 , through a cannula inserted into the superior mesenteric artery. Vascular responses were detected as changes in perfusion pressure; this was monitored continuously by way of a pressure transducer (Nihon Kohden, Model AP2001, Tokyo, Japan) and recorded on a pen recorder.
In the ®rst series of experiments, we examined the vasodilator responses of perfused mesenteric arterial beds to various agonists. Following a 60-min equilibration period, the perfusion circuit was transformed into a closed system by collecting the perfusate in a second bath and from thence recirculating it through the mesenteric arterial bed. The total volume of the closed system was 50 ml and agents were administered via the bath. In some preliminary experiments, the preparation of mesenteric arterial bed was constricted by perfusion with a solution containing 4610 76 to 3610 75 M methoxamine, which resulted in an increase in perfusion pressure of approximately 105 ± 120 mmHg, and then maximally relaxed with a perfusion solution containing 10 76 M ACh, a response which con®rmed the integrity of the endothelium in our preparation. In order to standardize the vasodilator responses obtained with dierent drugs, papaverine (10 74 M) was injected into each vascular bed and the resulting vasodilator response expressed as 100%. Each preparation received a dierent vasodilator agent. In each preparation, once the methoxamine-induced contraction had reached a plateau, vasodilator responses to a given agonist were elicited in a cumulative manner. To investigate the in¯uence of N G -nitro-L-arginine (L-NOARG), isotonic high K + (60 mM) or 10 75 M indomethacin on these agonistinduced responses, the mesenteric arterial bed was incubated in the appropriate solution for 30 min before the addition of methoxamine. To exclude the involvement of EDHF, some experiments were performed in which the preparation of the mesenteric arterial bed was depolarized with isotonic high K + (60 mM) in the presence of nicardipine (10 77 M); the mesenteric arteria bed was then constricted with methoxamine (4610 76 to 3610 75 M) (the starting pressure was adjusted to 105 ± 120 mmHg in this preparation). Each preparation was used to test only one antagonist or isotonic high K + medium. In a second series of experiments, we examined the eects of the application of K + (5 mM, so that the total K + concentration in the bath was 9.7 mM) in a single concentration-eect manner. In this series of experiments, propranolol (10 76 M), tetrodotoxin (10 76 M) and capsaicin (10 75 M) were used to exclude the in¯uence of other relaxing factors. 
Statistical analysis
Data are expressed as the mean+s.e.m. When appropriate, statistical dierences were assessed by Dunnett's test for multiple comparisons after a one-way analysis of variance. Statistical comparisons between concentration-response curves were made by means of a two-way ANOVA with Bonferroni's correction performed post hoc to correct for multiple comparisons. P50.05 was considered signi®cant in both types of test.
Results
General characteristics
Haemodynamic variables and the plasma levels of glucose, insulin, cholesterol and triglyceride were measured at 10 weeks after the STZ injection (Table 1) . By comparison with the agematched controls: (i) both systolic blood pressure and heart rate were lower in STZ-diabetic rats; (ii) the concentration of glucose in the plasma was elevated at 10 weeks; (iii) plasma insulin levels were signi®cantly lower in STZ-induced diabetes and (iv) plasma total cholesterol, high-density lipoprotein (HDL), low-density lipoprotein (LDL) cholesterol and triglyceride levels were all signi®cantly raised in STZ-induced diabetic rats.
Concentration-dependent vasodilator responses
The basal perfusion pressures in mesenteric arterial beds from STZ-induced diabetic rats and age-matched controls were 60.1+1.0 mmHg, n=10, and 64.0+1.7 mmHg, n=10, respectively (P40.05). Perfusion with methoxamine (4610 76 to 3610
increased the perfusion pressures to 108.7+4.3 mmHg (control, n=10), and 117.6+5.3 mmHg (diabetic, n=10), respectively. Therefore, the initial perfusion pressure was adjusted to 105 ± 120 mmHg in subsequent experiments under various experimental conditions.
In perfused mesenteric arterial beds preconstricted with methoxamine, infusion of cumulative concentrations of ACh (10 710 to 10 74 M) caused concentration-dependent vasodilatation. The vasodilatation induced by ACh was attenuated in STZ-diabetic rats (Figure 1 ). While the maximum vasodilatation was not dierent between age-matched controls and STZdiabetic rats, these groups diered signi®cantly in the sensitivity to ACh shown by their methoxamine-precontracted mesenteries (Table 2 and Figure 1 , inset). Table 2 and Figure 2 show the eects of various treatments on the ACh-induced vasodilator responses. In both control and diabetic mesenteric arterial beds, incubation with the nitric oxide synthase inhibitor L-NOARG (10 74 M) had no eect on the maximum vasodilatation to ACh but analysis of the whole dose-response curves showed a signi®cant right-ward shift for each group (control and diabetic). In the mesenteric arterial bed treated with L-NOARG (10 74 M), the concentration-response curve for ACh was signi®cantly dierent between controls (log EC 50 =77.81+0.08 M) and diabetic rats (log EC 50 = 76.62+0.25 M). In other preparations, pretreatment with isotonic high K + (60 mM) markedly reduced the vasodilatation induced by ACh in both groups and, under high K + , the maximum response in diabetes was not dierent from that in the control group. Moreover, in the mesenteric arterial bed treated with isotonic high K + , the concentration-response curves for ACh were comparable between controls (log EC 50 =76.74+0.18 M) and diabetic rats (log EC 50 = 76.57+0.06 M). No change in the ACh-induced concentration-response curve was produced by preincubation with indomethacin ( K + (5 mM) caused a vasodilatation of the mesenteric arterial bed from age-matched controls, the peak vasodilatation (at about 3 min) being by 26.7+2.03% (n=4). By contrast, the vasodilator response to this dose of K + (5 mM) was almost negligible in diabetic rats (2.27+4.70%, n=4) (Figure 4) . Preincubation with both charybdotoxin (10 77 M) plus apamin (10 77 M) signi®cantly enhanced the 5 mM K + -induced vasodilatation in mesenteric arterial beds from the agematched controls and tended to enhance it in the diabetics. However, the vasodilatation induced by 5 mM K + was signi®cantly attenuated, even reversal, in the presence of ouabain (10 73 M) plus BaCl 2 (5610 74 M) ( Figure 5 ). To make a comparison with this result, we also examined the eect of these antagonists on the ACh-induced vasodilatation in the presence of indomethacin and L-NOARG. In both age- matched control and diabetic rats, the ACh-induced vasodilatation was almost completely abolished by charybdotoxin plus apamin, while pretreatment with ouabain and BaCl 2 signi®cantly reduced the ACh response in both groups ( Figure  6 ). As can be seen in Figure 6b , there was no dierence between control and diabetic mesenteric arterial beds in the response to ACh in the presence of ouabain plus BaCl 2 . The vasodilatations induced by 5 mM K + were not aected by the removal of the endothelium in both control and diabetic rats (Figure 7, upper 
Discussion
The major conclusion to be drawn from the present study is that the impairment of the ACh-induced endotheliumdependent vasodilatation that is seen in mesenteric arterial beds from diabetic rats may be due largely to a defective In the present study, we also found that K + was able to induce a decrease in the perfusion pressure of the control mesenteric arterial bed and that this response was greatly attenuated in the diabetic state.
In the present study, our ®rst ®nding was that the endothelium-dependent vasodilator response of the mesenteric arterial bed to ACh was attenuated in STZ-induced diabetic rats. PGI 2 has been found to contribute to endotheliumdependent relaxation in several isolated blood vessels and to contribute to vasodilatation in perfused organs (Vegesna & Diamond, 1986) . It has been reported that the release from the mesenteric arterial bed of 6-keto-prostaglandin F 1a (a metabolite of PGI 2 ), thromboxane B 2 (TXB 2 , a metabolite of thromboxane A 2 ) and PGE 2 is signi®cantly greater in diabetic rats than in controls (Fujii et al., 1986; Koltai et al., 1997) . However, in the present study, pretreatment with indomethacin had no eect on the ACh-induced dose-dependent vasodilatation in either control or diabetic rats, suggesting that prostanoids are not involved in the ACh-induced vasodilatation in mesenteric arterial beds.
In the analysis presented in this paragraph and the next, we focus on the residual vasodilatation seen under L-NOARG or high K + . Under a high concentration of L-NOARG, the residual vasodilatation can be assumed to represent the component of the vasodilatation mediated by EDHF. On the other hand, the residual vasodilatation seen when the bed was fully depolarized by high K + (60 mM) can be assumed to represent the component mediated by NO. The ACh-induced vasodilatation in the presence of L-NOARG was signi®cantly weaker in the diabetic mesenteric vessels than in the control mesenteric vessels, suggesting that the release or synthesis of EDHF in the diabetic state may be reduced by comparison with that in the controls. When the mesenteric arterial bed was fully depolarized with high K + , the ACh dose-response curve was almost the same in controls and diabetic rats, suggesting that the NO-mediated component of the vasodilatation induced by ACh may be comparable between controls and diabetic rats. As shown in Table 1 , there is a marked increase in plasma LDL concentration in the diabetic state, indicating that the impairment of the EDHF-mediated response may be, at least in part, due to the increase in plasma LDL. Indeed, one possible explanation for the decreased EDHF-mediated vasodilatation may be the following sequence of events: STZ-diabetes leads to an increase in plasma LDL cholesterol and a decrease in superoxide dismutase contents of blood vessels and activity (Kamata & Kobayashi, 1996; Kobayashi & Kamata, 1999) ; the decreased superoxide dismutase activity causes an increased accumulation of superoxide anions; the accumulated superoxide anions may oxidize LDL (Kobayashi & Kamata, 1999) ; the oxidized LDL may itself impair the EDHF-mediated response and/or the oxidized LDL may release lysophosphatidylcholine (LPC) which then attenuates the EDHF-mediated hyperpolarization (Fukao et al., 1995) ; the oxidized LDL or LPC may also inhibit Ca 2+ in¯ux into the STZ-diabetes and EDHF 553 A. Makino et al endothelium (Kamata & Nakajima, 1998) , thus reducing the production or release of EDHF (since this requires an increase in intracellular Ca 2+ in the endothelium, Chen & Suzuki, 1990) . As a result, the ACh-induced vasodilatation in the presence of L-NOARG would be signi®cantly impaired in the mesenteric arterial beds from diabetic rats (Figure 2) .
Recently, it has been reported that K + is one candidate for EDHF in rat arteries (Edwards et al., 1998) . The sequence would be that when ACh binds to its receptors on the endothelium, charybdotoxin-and apamin-sensitive K + channels in the endothelium are opened and K + eux occurs into the myoendothelial space. The resulting increase in myoendothelial K + concentration hyperpolarizes and relaxes adjacent smooth muscle cells by activating Ba 2+ -sensitive K + channels and ouabain-sensitive Na + , K + ATPase. There are other candidates for EDHF, namely endocannabinoids, anadamide and epoxyeicosatrienoic acids (EETs), which are cytochrome-P450-monooxygenase-derived metabolites of arachidonic acid (Mombouli & Vanhoutte, 1997; Campbell et al., 1996; Hecker et al., 1994; Randall & Kendall, 1998; Fisslthaler et al., 1999) . Furthermore, recent evidence suggests that direct heterocellular gap junctional communication between endothelium and smooth muscle may contribute to NOindependent relaxation (Chaytor et al., 1998; Hutcheson et al., 1999; Yamamoto et al., 1998; . In the present study, we focused on K + as a possible candidate for EDHF. K + (5 mM) caused a vasodilatation of the mesenteric arterial bed from age-matched controls, the peak vasodilatation being by 26.7+2.03%, while the vasodilator response to this concentration of K + was almost negligible in diabetic rats. Although we do not know the precise identity of the mechanisms underlying the vasodilator response of the mesenteric arterial bed to K + , this is the ®rst report that K + -induced vasodilatation is attenuated in the diabetic state.
Although incubating the mesenteric arterial bed with charybdotoxin (10 77 M) plus apamin (10 77 M) enhanced the 5 mM K + -induced vasodilatation, the vasodilatation induced by ACh was completely abolished by these agents in both agematched controls and diabetics, suggesting that an action of K + on smooth muscle may not be responsible for the AChinduced vasodilatation. The vasodilatation induced by 5 mM K + was converted to a small contraction in controls and diabetics by treatment with ouabain (10 73 M) plus BaCl 2 (5610 74 M). The result is consistent with recent evidence that the K + -induced hyperpolarization and relaxation in rat mesenteric artery are signi®cantly inhibited by ouabain plus Ba 2+ (Edwards et al., 1998) . For comparison with this result, we also examined the eect of these agents on the AChinduced vasodilatation in the presence of indomethacin and L-NOARG. In both age-matched control and diabetic rats, the ACh-induced vasodilatation was almost abolished by charybdotoxin plus apamin and was also slightly, but signi®cantly, inhibited by treatment with ouabain plus BaCl 2 , suggesting Figure 6b , there was no dierence between control and diabetic mesenteric arterial beds in the response to ACh in the presence of ouabain plus BaCl 2 , suggesting that the defect in diabetes is in the response to K + . To examine the ACh-or K + -induced vasodilatation in the mesenteric arterial beds, we used a high concentration of Ba , and the vasodilatation induced by pinacidil, a K + -channel opener (Carlsen et al., 1981) , and the vasoconstriction induced by methoxamine were not aected by the concentration of Ba
2+
. These results suggest that a high concentration of Ba 2+ alone has non-speci®c action of K + -channel.
When we examined the K + -induced vasodilatation in the perfused mesenteric arterial beds, the beds were treated with propranolol, tetrodotoxin, capsaicin, L-NOARG and indomethacin, suggesting that the vasodilatation induced by K + is not related to the release of noradrenaline, vasoactive intestinal polypeptide, calcitonin-gene related peptide, NO and prostaglandins. The vasodilator responses of the mesenteric arterial beds to ACh in the presence of high K + were completely inhibited in the presence of L-NOARG plus indomethacin and incubating the mesenteric arterial bed with indomethacin alone had no in¯uence on the ACh-induced vasodilatation. These results strongly suggest that EDRF released from the endothelium of the mesenteric arterial bed may be NO and EDHFs.
In conclusion, our results suggest that the impairment of the endothelium-dependent vasodilatation of the mesenteric arterial bed seen in STZ-induced diabetic rats may be largely due to a defecting vascular response to K + . It is further suggested that K + may be one of the EDHFs. Although the precise identity of the mechanisms underlying attenuation of the K + -induced vasodilatation in the mesenteric arterial bed from diabetic rats is not yet clear, K + may play an important role in this aspect of the pathogenesis of diabetes mellitus.
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